Table 2.
Characteristics of 20 animal studies (21 experiments).
Reference | Animal model | N | Injury type | Control group(s) | Intervention | Via | Initiation of intervention | Other doses | Follow-up |
---|---|---|---|---|---|---|---|---|---|
Abdel-Baki et al. (37) | Sprague–Dawley rats, 250–300 g | NR | CCI, moderate |
|
NAC 150 mg/kg | IP | 1 h | Once daily on days 1 and 2 | 1 week |
Chen et al. (38) | Wistar rats, 250–300 g | 51 | Weight drop, moderate |
|
NAC 150 mg/kg | IP | 15 min | Once daily on days 1, 2, and 3 | 3 days |
Du et al. (39) | Long Evans pigmented rats, 360–400 g | 74 | Blast exposure, 14psi, mild | Normal control | NAC 300 mg/kg HPN-07 98.5% |
IP | 1 h | Twice daily on days 1 and 2 | 7, 14, and 21 days |
Eakin et al. (40) | 1. Sprague–Dawley rats. 350–400 g | 26 | FPI, 1.8–1.9 atm, mild |
|
NAC 50 mg/kg | IP | 30 min | Once daily on days 1, 2 and 3 | 14 days |
Eakin et al. (40) | ICR mice, 30–40 g | 32 | Weight drop, ~30 g, mild |
|
NAC 100 mg/kg | IP | 1 h | NR | 7 days |
Topiramate 30 mg/kg | 30 days | ||||||||
Ellis et al. (41) | Cats | 17 | FPI, mild | Injury | 1. Pre-TBI 326 mg/kg 2. Post-TBI 163 mg/kg |
IP | 30 min | NR | 80 min |
Ewert et al. (42) | Long Evans pigmented rats, 360–400 g | 48 | Blast exposure, ~ 14psi, mild | Injury | NAC 300 mg/kg HPN-07 300 g/kg |
IP | 1 h | Twice daily for 2 days | 3 and 24 h 7 days and 21days |
Gunther et al. (43) | Sprague–Dawley rats, 250–400 g | 24 | Penetrating ballistic like, moderate |
|
NACA 300 mg/kg | IP | 2 min | 24 h survivors 300 mg/kg | 2 and 24 h |
Haber et al. (44) | Sprague–Dawley rats, 250–300 g | NR | CCI, moderate |
|
1. NAC 150 mg/kg 2. NAC 150 mg/kg + minocycline 45 mg/kg |
IP | 1 h | Once daily on days 1 and 2 | 31 days |
Hicdonmez et al. (45) | Sprague–Dawley rats, 280–320 g | 36 | Weight drop ~0.5J, moderate |
|
NAC 150 mg/kg | IP | 15 min | NR | 2 and 12 h |
Kawoos et al. (46) | Sprague–Dawley rats, 300–350 g | 88 | Blast overpressure, mild | Placebo (6 groups based on repetitive BOP) | NACA 500 mg/kg in each group, for 6 different groups | IP | 2 h in 6 groups and 15 min prior TBI in 1 group | 1 group: NACA at 2 + 4 h post TBI | 7 days |
Naziroglu et al. (47) | Sprague–Dawley rats, 330 ± 20g | 36 | Weight drop contusion, moderate |
|
NAC 150 mg/kg | Oral | 1 h | Once at 24 h, 48 h, and 72 h | 3 days |
Pandya et al. (48) | Sprague–Dawley rats, 300–350 g | 51 | CCI, moderate | TBI + vehicle | 1. NAC 150 mg 2. NACA 150 mg/kg and 18.5 mg/kg/h |
IP | 5–30 min | 18.5 mg/kg/h NAC, NACA or vehicle | 25 h to 15 days |
Senol et al. (20) | Sprague–Dawley rats, 300–340 g | 36 | Weight drop, moderate |
|
NAC 150 mg/kg | Oral | 1 h | Once at 24 h, 48 h, and 72 h | 4 weeks |
Silva et al. (49) | Wistar rats,270–300 g | NR | FPI, moderate | Injury + NS | NAC 100 mg/kg | Oral | Immediately | Once daily for 5 weeks | 5 weeks |
Thomale et al. (50) | Sprague–Dawley rats, 300–350 g | 48 | CCI, moderate |
|
NAC 163 mg/kg | IP | Immediately | 2 and 4 h | 24 h |
Thomale et al. (51) | Sprague–Dawley rats, 300–350 g | 62 | CCI, moderate |
|
NAC 163 mg/kg | IP | 15 min | 2 and 4 h | 24 h |
Xiong et al. (52) | Sprague–Dawley rats, 200–350 g | NR | CCI, moderate |
|
NAC 163 mg/kg | IP | 4 groups:
|
2 groups post TBI:
|
12 hours 14 days |
Xiong et al. (53) | Sprague–Dawley rats, 200–350 g | NR | CCI, moderate |
|
NAC 163 mg/kg | IP | 30 min | NR | 1, 4 and 12 h 1 and 14 days |
Yiand Hazell (54) | Sprague–Dawley rats, 200–350 g | 64 | FPI, moderate |
|
NAC 163 mg/kg | IP | 5 min | 6 and 24 h | 6 and 24 h |
Yi et al. (55) | Sprague–Dawley rats, 200–350 g | 66 | FPI, moderate |
|
NAC 163 mg/kg | IP | 5 min | NR | 6 and 24 h3 and 7 days |
atm, atmospheric pressure; BOP, blast overpressure; CCI, controlled cortical impact; DMSO, dimethyl sulfoxide; FPI, fluid percussion injury; HPN, 2,4-disulfonyl α-phenyl tertiary butyl nitrone; ICR, imprinting control region; IP, intra-peritoneal; NACA, n-acetylcysteine amide; NAC, n-acetylcysteine; NR, not reported; NS, normal saline; PSI, pounds per square inch; Se, selenium; TBI, traumatic brain injury.